The evaluation and management of acute, severe asthma

Medical Clinics of North America

Volumn 86, Issue 5, 2002, Pages 1049-1071

  Siwik, Jaroslaw P ^a   Nowak, Richard M ^a   Zoratti, Edward M ^a  

^a HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ADRENERGIC RECEPTOR STIMULATING AGENT; ALLOPURINOL; AMINOPHYLLINE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BITOLTEROL; BRONCHODILATING AGENT; BUDESONIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CIMETIDINE; CIPROFLOXACIN; CORTICOSTEROID; CYSTEINYLLEUKOTRIENE RECEPTOR BLOCKING AGENT; FLUNISOLIDE; IPRATROPIUM BROMIDE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LEVALBUTEROL; MACROLIDE; MAGNESIUM SULFATE; METHYLPREDNISOLONE; MONTELUKAST; PIRBUTEROL; PREDNISOLONE; PREDNISONE; PROPRANOLOL; SALBUTAMOL; TERBUTALINE; THEOPHYLLINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZAFIRLUKAST;

ABDOMINAL PAIN; ADRENERGIC ACTIVITY; AGITATION; AIRWAY OBSTRUCTION; ASTHMA; BRONCHODILATATION; CARDIOTOXICITY; CLINICAL TRIAL; CONFUSION; CORTICOSTEROID THERAPY; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; ELECTROLYTE DISTURBANCE; FLUID THERAPY; FLUSHING; HEADACHE; HEART ARRHYTHMIA; HOSPITALIZATION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPOKALEMIA; HYPOMAGNESEMIA; HYPOPHOSPHATEMIA; HYPOREFLEXIA; HYPOTENSION; LEUKOCYTOSIS; META ANALYSIS; METERED DOSE INHALER; NAUSEA; NEBULIZATION; NERVOUSNESS; OXYGEN THERAPY; PRIORITY JOURNAL; RESPIRATION DEPRESSION; RESPIRATORY ALKALOSIS; RESPIRATORY FAILURE; REVIEW; RISK FACTOR; SEDATION; SEIZURE; SIDE EFFECT; SOMNOLENCE; TACHYCARDIA; TREATMENT OUTCOME; VASOCONSTRICTION; VOMITING;

ACUTE DISEASE; ASTHMA; HUMANS; SEVERITY OF ILLNESS INDEX;

EID: 0036710967     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7125(02)00033-0     Document Type: Review

References (117)

1. British Thoracic Society and others. Guidelines on the management of asthma. Thorax 1993;48:S1-S24.
2. British Thoracic Society, Research Unit of the Royal College of Physicians of London, King's Fund Centre. National Asthma Campaign. Guidelines for management of asthma in adults. II-acute severe asthma. BMJ 1990;301:767-800.
3. Guidelines for the management of asthma: A summary. BMJ 1993;306:776-82.
4. International Consensus Report on the Diagnosis and Management of Asthma. Clin Exp Allergy 1992;22:1-72.
5. National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Program Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma. Publ No. 55-4051. Bethesda: National Institutes of Health; 1997.
6. Nowak RM. National and international guidelines for the emergency management of adult asthma. In: Brenner BE, editor. Emergency asthma. New York: Marcel Dekker; 1999. p. 284-305.
7. Greenberger PA, Miller TP, Lifschultz B. Circumstances surrounding deaths from asthma in Cook County (Chicago) Illinois. Allergy Asthma Proc 1993;14:321-6.
8. Kallenbach JM, Frankel AH, Lapinsky SE, et al. Determinants of near fatality in acute severe asthma. Am J Med 1993;95:265-72.
9. O'Hallaren MT, Yunginger JW, Offord KP, et al. Exposure to an aeroallergen as a possible precipitating factor in respiratory arrest in young patients with asthma. N Engl J Med 1991;324:359-63.
10. Rodrigo G, Rodrigo C. Assessment of the patient with acute asthma in the emergency department: A factor analytic study. Chest 1993;104:1325-8.
11. Suissa S, Blais L, Ernst P. Patterns of increasing beta-agonist use and the risk of fatal or near-fatal asthma. Eur Respir J 1994;7:1602-9.
12. Tuxen DV, Anderson MB, Scheinkestel CD. Mechanical ventilation for severe asthma. In: Hall JB, Corbridge TC, Rodrigo C, et al, editors. Acute Asthma: Assessment and Management. New York: McGraw-Hill; 2000. p. 209-28.
13. Wasserfallen J, Schaller M, Feihl F, et al. Sudden asphyxic asthma: A distinct entity? Am Rev Respir Dis 1990;142:108-111.
14. Robin E, Lewiston N. Unexpected, unexplained sudden death in young asthmatic subjects. Chest 1989;96:790-3.
15. Hetzel M, Clark T, Branthwaite M. Asthma: Analysis of sudden deaths and ventilatory arrests in hospital. BMJ 1977;1:808-11.
16. Strunk RC. Identification of the fatality-prone subject with asthma. J Allergy Clin Immunol 1989;83:477-85.
17. Molofino N, Nannini L, Martelli A, et al. Respiratory arrest in near-fatal asthma. N Engl J Med 1991;324:285-8.
18. Williams T, Tuxen D, Scheinkestel C, et al. Risk factors for morbidity in mechanically ventilated patients with acute severe asthma. Am Rev Respir Dis 1992;146:607-15.
19. Shim CS, Williams MH. Evaluation of the severity of asthma: Patients versus physicians. Am J Med 1980;68:11-3.
20. Nowak RM, Tomlanovich MC, Sarker DD, et al. Arterial blood gases and pulmonary function testing in acute bronchial asthma: Predicting patient outcomes. JAMA 1983;249:2043-6.
21. Bodenhammer J, Bergstrom R, Brown D, et al. Frequently nebulized beta-agonists for asthma: Effects on serum electrolytes. Ann Emerg Med 1992;21:1337-42.
22. Heimer D, Shim C, Williams MH. The effect of sequential inhalations of metaproterenol aerosol in asthma. J Allergy Clin Immunol 1980;66:75-7.
23. Lin RY, Sauter D, Newman T, et al. Continuous versus intermittent albuterol nebulization in the treatment of acute asthma. Ann Emerg Med 1993;22:1847-53.
24. Lipworth BJ, Clark RA, Dhillon DP, et al. Beta-adrenoceptor responses to high doses of inhaled salbutamol in patients with bronchial asthma. Br J Clin Pharmacol 1988;26:527-33.
25. Rudnitsky GS, Eberlein RS, Schoffstall JM, et al. Comparison of intermittent and continuously nebulized albuterol for treatment of asthma in an urban emergency department. Ann Emerg Med 1993;22:1842-6.
26. Robertson CF, Smith F, Beck R, et al. Response to frequent low doses of nebulized salbutamol in acute asthma. J Pediatr 1985;106:672-4.
27. Jenne JW. The debate on S-enantiomers of B-agonists: Tempest in a teapot or a gathering storm? J Allergy Clin Immunol 1998;102:893-5.
28. Mitra S, Ugur M, Ugur O, et al. (S)-albuterol increases intracellular free calcium by muscarinic receptor activation and phospholipase C-dependent mechanism in airway smooth muscle. Mol Pharmacol 1998;53:347-54.
29. Dhand R, Goode M, Ried R, et al. Preferential pulmonary retention of (S)-albuterol after inhalation of racemic albuterol. Am J Respir Crit Care Med 1999;160:1136-41.
30. Page CP, Morley J. Contrasting properties of albuterol stereoisomers. J Allergy Clin Immunol 1999;104(2 pt 2):S31-41.
31. Gawchik SM, Saccar CL, Noonan M, et al. The safety and efficacy of nebulized levalbuterol compared with raceinic albuterol and placebo in the treatment of asthma in pediatric patients. J Allergy Clin Immunol 1999;103:615-21.
32. Handley DA, Tinkelman D, Noonan M, et al. Dose-response evaluation of levalbuterol versus racemic albuterol in patients with asthma. J Asthma 2000;37:319-27.
33. Nelson HS, Bensch G, Pleskow WW, et al. Improved bronchodilation with levalbuterol compared with racemic albuterol in patients with asthma. J Allergy Clin Immunol 1998; 102(6 part 1):943-52.
34. Nowak RM, Emerman CL. Levalbuterol is effective in acute asthma. Am J Respir Crit Care Med 2001;163:A590.
35. Milgrom H, Skoner DP, Bensch G. Low-dose levalbuterol in children with asthma: Safety and efficacy in comparison with placebo and racemic albuterol. J Allergy Clin Immunol 2001;108:938-45.
36. Lötvall J, Palmqvist M, Arvidsson P, et al. The therapeutic ratio of R-albuterol is comparable with that of RS-albuterol in asthmatic patients. J Allergy Clin Immunol 2001;108:726-31.
37. Colacone A, Afilalo M, Wolkove N, et al. A comparison of albuterol administered by metered dose inhaler (and holding chamber) or wet nebulizer in acute asthma. Chest 1993;104:835-41.
38. Idris AH, McDermott MF, Raucci JC, et al. Emergency department treatment of severe asthma: Metered-dose inhaler plus holding chamber is equivalent in effectiveness to nebulizer. Chest 1993;103:665-72.
39. Kerem E, Levison H, Schuh S, et al. Efficacy of albuterol administered by nebulizer versus spacer device in children with acute asthma. J Pediatrics 1993;123:313-7.
40. Aaron SD. The use of ipratropium bromide for the management of acute asthma exacerbation in adults and children: A systemic review. J Asthma 2001;38:521-30.
41. 2-agonists for treating acute childhood and adolescent asthma? A systemic review. BMJ 1998; 317:971-7.
42. Qureshi F, Pestian J, Davis P, et al. Effect of nebulized ipratropium on hospitalization rates of children with asthma. N Engl J Med 1998;339:1030-5.
43. Zorcc JJ, Pusic MV, Ogborn CJ, et al. Ipratropium bromide added to asthma treatment in the pediatric emergency department. Pediatrics 1999;103:748-52.
44. Lanes SF, Garrett JE, Wentworth CE III, et al. The effect of adding ipratropium bromide to salbutamol in the treatment of acute asthma: A pooled analysis of three trials. Chest 1998;1114:365-72.
45. Rodrigo G, Rodrigo C, Burschtin O. A meta-analysis of the effects of ipratropium bromide in adults with acute asthma. Am J Med 1999;107:363-70.
46. Rodrigo GJ, Rodrigo C. First-line therapy for adult patients with acute asthma receiving a multiple-dose of ipratropium bromide plus albuterol in the emergency department. Am J Respir Crit Care Med 2000;161:1862-8.
47. Stoodley RG, Aaron SD, Dales RE. The role of ipratropium bromide in the emergency management of acute asthma exacerbations: A meta-analysis of randomized clinical trials. Ann Emerg Med 1999;34:8-18.
48. Fanta CH, Rossing TH, McFadden ER Jr. Glucocorticoids in acute asthma: A critical controlled trial. Am J Med 1983;74:845-51.
49. Chapman KR, Verbeek PR, White JG, et al. Effect of a short course of prednisone in the prevention of early relapse after emergency room treatment of acute asthma. N Engl J Med 1991;324:788-94.
50. Benatar SR. Fatal asthma. N Engl J Med 1986;314:423-9.
51. Littenberg B, Gluck EH. A controlled trial of methylprednisolone in the emergency treatment of acute asthma. N Engl J Med 1986;314:150-2.
52. Connett GJ, Warde C, Wooler E, et al. Prednisolone and salbutamol in the hospital treatment of acute asthma. Arch Dis Child 1994;70:170-3.
53. Rowe BH, Keller JL, Oxman AD. Effectiveness of steroid therapy in acute exacerbations of asthma: A meta-analysis. Am J Emerg Med 1992;10:301-10.
54. Rowe BH, Spooner C, Ducharme FM, et al. Early emergency department treatment of acute asthma with systemic corticosteroids. Cochrane Database of Systemic Reviews [Computer File] 2000;2:CD002178.
55. Silverman R. Treatment of acute asthma: a new look at the old and at the new. Clin Chest Med 2000;21:361-79.
56. Rowe BH, Botak GW, Fabris L, et al. Inhaled budesonide in addition to oral corticosteroids to prevent asthma relapse following discharge from the emergency department: A randomized controlled trial. JAMA 1999;281:2119-26.
57. Haalboon JRE, Denstra M, Stuyvenberg A. Hypokalemia induced by inhalation of fenoterol. Lancet 1985;1:1125-7.
58. Rodrigo C, Rodrigo G. Therapeutic response patterns to high and cumulative doses of salbutamol in acute severe asthma. Chest 1998;113:593-8.
59. Strauss L, Hejal R, Galan G, et al. Observations on the effects of aerosolized albuterol in acute asthma. Am J Respir Crit Care Med 1997;155:454-8.
60. Green SM, Rothrock SG. Intravenous magnesium for acute asthma: Failure to decrease emergency treatment duration or need for hospitalization. Ann Emerg Med 1992;21:260-5.
61. Kuitert LM, Kletchko SL. Intravenous magnesium sulfate in acute, life threatening asthma (erratum in Ann Emerg Med 1992;21:1272). Ann Emerg Med 1991;20:1243-5.
62. Skorodin MS, Tenholder MF, Yetter B, et al. Magnesium sulfate in exacerbations of chronic obstructive pulmonary disease. Arch Intern Med 1995;155:496-500.
63. Tiffany BR, Berk WA, Todd IK, et al. Magnesium bolus or infusion fails to improve expiratory flow in acute asthma exacerbations. Chest 1993;104:831-4.
64. Bloch H, Silverman R, Mancherje N, et al. Intravenous magnesium sulfate as an adjunct in the treatment of acute asthma. Chest 1995;107:1576-81.
65. Mangat HS, D'Souza GA, Jacob MS. Nebulized magnesium sulfate versus nebulized salbutamol in acute bronchial asthma: A clinical trial. Eur Respir J 1998;12:341-4.
66. Nannini LJ Jr., Pendino JC, Corna RA, et al. Magnesium sulfate as a vehicle for nebulized salbutamol in acute asthma. Am J Med 2000;108:193-7.
67. Pavord ID, Ward R, Woltmann G, et al. Induced sputum eicosanoid concentrations in asthma. Am J Respir Crit Care Med 1999;160:1905-9.
68. Dockhorn RJ, Baumgartner RA, Leff JA, et al. Comparison of the effects of intravenous and oral montelukast on airway function: A double blind, placebo controlled, three period, crossover study in asthmatic patients. Thorax 2000;55:260-5.
69. Silverman RA, Chen Y, Bonucelli CM, et al. The Zafirlukast Acute Asthma Study Group: Zafirlukast improves emergency department outcomes after an acute asthma episode. Ann Emerg Med 2000;35:S10.
70. Carmago CA, Green SA, Smithline HA, et al. Rapid bronchodilator response to intravenous montelukast in acute asthma [abstract]. Acad Emerg Med 2001;8:414.
71. Rodrigo GJ, Rodrigo C. Inhaled flunisolide for acute severe asthma. Am J Respir Crit Care Med 1998;157:698-703.
72. Devidayal, Singhi S, Kumar L, et al. Efficacy of nebulized budesonide compared to oral prednisone in acute bronchial asthma. Acta Paediatr 1999;88:835-40.
73. Kumar SD, Brieva JL, Danta I, et al. Transient effect of inhaled fluticasone on airway mucosal blood flow in subjects with and without asthma. Am J Respir Crit Care Med 2000;161:918-21.
74. Hargreaves FE, Dolovich J, Newhouse MT, editor. The assessment and treatment of asthma: A conference report. J Allergy Clin Immunol 1990;85:1098-111.
75. Maguire JF, O'Rourke PP, Colan SD, et al. Cardiotoxicity during treatment of severe childhood asthma. Pediatrics 1991;88:1180-6.
76. Nowak RM, Tokarski G. Asthma. In: Falk K, Stein D, editors. Rosen's emergency medicine: concepts and clinical practice. 5th edition. St. Louis: Mosby; 2000. p. 938-56.
77. Simons EF, Ziaochen G, Simons KJ. Epinephrine absorption in adults: Intramuscular versus subcutaneous injection. J Allergy Clin Immunol 2001;108:871-3.
78. Bishop GF, Hillman KM. Acute severe asthma. Intensive Care World 1993;10:166-71.
79. Coleridge J, Cameron P, Epstein J, et al. Intravenous aminophylline confers no benefit in acute asthma treated with intravenous steroids and inhaled bronchodilators. Aust N Z J Med 1993;23:348-54.
80. Littenberg B. Aminophylline treatment in severe acute asthma: A meta-analysis. JAMA 1988;259:1678-84.
81. Murphy DG, McDermott MF, Rydman RJ, et al. Aminophylline in the treatment of acute asthma when beta 2-adrenergics and steroids are provided. Arch Intern Med 1993;153:1784-8.
82. Rodrigo C, Rodrigo G. Treatment of acute asthma: Lack of therapeutic benefit and increase of the toxicity from aminophylline given in addition to high doses of salbutamol delivered by metered-dose inhaler with a spacer. Chest 1994;106:1071-6.
83. Huang D, O'Brien RG, Harman E, et al. Does aminophylline benefit adults admitted to the hospital for an acute exacerbation of asthma? Ann Intern Med 1993;119:1155-60.
84. Wrenn K, Slovis CM, Murphy F, et al. Aminophylline therapy for acute bronchospastic disease in the emergency room. Ann Intern Med 1991;115:241-7.
85. Yung M, South M. Randomised controlled trial of aminophylline for severe acute asthma. Arch Dis Child 1998;79:405-10.
86. Emerman CL, Nowak RM, Tomlanovich MC. Theophylline concentrations in the emergency treatment of acute bronchial asthma. Am J Emerg Med 1983;1:12-6.
87. Berkovich S, Millian SJ, Snyder RD. The association of viral and mycoplasma infections with recurrence of wheezing in the asthmatic child. Ann Allergy 1970;28:43-9.
88. Friedman R, Ackerman M, Wald E, et al. Asthma and bacterial sinusitis in children. J Allergy Clin Immunol 1984;74:185-9.
89. Johnsonton SL. Influence of viral and bacterial respiratory infections on exacerbations and symptom severity in childhood asthma. Pediatr Pulmonol Suppl 1997;16:88-9.
90. Johnston SL, Pattemore PK, Sanderson G, et al. The relationship between upper respiratory infections and hospital admissions for asthma: A time-trend analysis. Am J Respir Crit Care Med 1996;154:654.
91. Miyashita N, Kubota Y, Nakjima M, et al. Chlamydia pneumoniae and exacerbations of asthma in adults. Ann Allergy Asthma Immunol 1998;80:405-9.
92. Nicholson KG, Kent JK, Ireland DC. Respiratory viruses and exacerbations of asthma in adults. BMJ 1993;307:982.
93. Oehling AK. Bacterial infection as an important triggering factor in bronchial asthma. J Investig Allergol Clin Immunol 1999;9:6-13.
94. Seffev JS, Lis I, Siman-Tov S, et al. Mycoplasma pneumoniae is a frequent cause of exacerbation of bronchial asthma in adults. Ann Allergy 1986;57:262-5.
95. Spagnolo SV. Status asthmaticus and hospital management of asthma. Immunology and Allergy Clinics of North America 2001;57:21503-33.
96. Black PN, Blasi F, Jenkins C, et al. Trial of roxithromycin in subjects with asthma and serological evidence of infection with Chlamydia pneumoniae. Am J Respir Crit Care Med 2001;164:536-41.
97. Senior BA, Kennedy DW. Management of sinusitis in the asthmatic patient. Ann Allergy Asthma Immunol 1996;77:6-19.
98. Bernstein IL, Ausdenmoore RW. Iatrogenic bronchospasm occurring during clinical trials of a new mucolytic agent, acetyl cysteine. Dis Chest 1964;46:469.
99. Fish JE, Peters SP. Bronchial challenge testing. In: Middleton E Jr, Reed C, Ellis EF, et al, editors. Allergy Principles and Practice. 5th Edition. New York: Mosby; 1998. p. 454-64.
100. Roquet A, Dahlen B, Kumlin M, et al. Combined antagonism of leukotrienes and histamine produces predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics. Am J Respir Crit Care Med 1997;155:1856-63.
101. Manthous CA, Hall JB, Caputo MA, et al. Heliox improves pulsus paradoxus and peak expiratory flow in nonintubated patients with severe asthma. Am J Respir Crit Care Med 1995;151:310-4.
102. Kudukis TM, Manthous CA, Schmidt GA, et al. Inhaled helium-oxygen revisited: Effect of inhaled helium-oxygen during treatment of status asthmaticus in children. J Pediatr 1997;130:217-24.
103. Kass JE, Terregion CA. The effect of heliox in acute severe asthma. Chest 1999;116:296-300.
104. Carter ER, Webb CR, Moffitt DR. Evaluation of heliox in children hospitalized with acute severe asthma: A randomized crossover study. Chest 1996;109:1256-61.
105. 1 in acute asthma patients. J Emerg Med 1998;16:545-8.
106. Hess D, Chatmongkolchart S. Techniques to avoid intubation: Noninvasive positive pressure ventilation and heliox therapy. Int Anesthesiol Clin 2000;38:161-87.
107. Bianco S, Pieroni MG, Refini RM, et al. Protective effect of inhaled furosemide on allergen-induced early and late asthmatic reactions. N Engl J Med 1989;321:1069-73.
108. Karpel JP, Dworkin F, Hager D, et al. Inhaled furosemide is not effective in acute asthma. Chest 1994;106:1396-400.
109. Howton JC, Rose J, Duffy S, et al. Randomized, double-blind, placebo-controlled trial of intravenous ketamine in acute asthma. Ann Emerg Med 1996;27:170-5.
110. Echeverria M, Gelb AW, Wexler HR, et al. Enflurane and halothane in status asthmaticus. Chest 1986;89:152-4.
111. Johnston RG, Noseworthy TW, Friesen EG, et al. Isoflurane therapy for status asthmaticus in children and adults. Chest 1990;97:698-701.
112. Meduri GU. Noninvasive positive-pressure ventilation in patients with acute respiratory failure. Clin Chest Med 1996;17:513-53.
113. Cohen N, Eigen H, Shaughnessy T. Status asthmaticus. Crit Care Clin 1997;17:459-75.
114. Levy B, Kitch B, Fanta C. Medical and ventilatory management of status asthmaticus. Intensive Care Med 1998;24:105-17.
115. American Respiratory Care Foundation. Consensus conference: Noninvasive positive pressure ventilation. Respir Care 1997;42:364-9.
116. Smith SR, Strunk RC. Acute asthma in the pediatric emergency department. Pediatr Clin North Am 1999;46:1145-65.
117. Ferrer A, Torres A, Roca J, et al. Characteristics of patients with soybean dust-induced acute severe asthma requiring mechanical ventilation. Eur Respir J 1990;3:429-33.